A5069836243- Antiplatelet Therapy and Cardiovascular Diseases
- Coronary Interventions and Diagnostics
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Cardiac Imaging and Diagnostics
- Renal and Vascular Pathologies
- Heart Failure Treatment and Management
- Machine Learning in Healthcare
- Diabetes Treatment and Management
- Cerebrovascular and Carotid Artery Diseases
- Dialysis and Renal Disease Management
- Radiation Dose and Imaging
- Acute Kidney Injury Research
- Cardiac, Anesthesia and Surgical Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Cardiac Arrest and Resuscitation
- Potassium and Related Disorders
- Pharmaceutical Economics and Policy
- Ultrasound in Clinical Applications
- Transplantation: Methods and Outcomes
- Pharmacological Effects and Toxicity Studies
- Topic Modeling
- Atrial Fibrillation Management and Outcomes
- Artificial Intelligence in Healthcare
- Renal Transplantation Outcomes and Treatments
University of Illinois Chicago
2015-2024
Illinois College
2022-2024
University of Illinois Urbana-Champaign
2021-2024
Jesse Brown VA Medical Center
2016-2018
University of Illinois Hospital & Health Sciences System
2017
University of Michigan–Ann Arbor
2012
Beaumont Health
2012
Trinity Health Ann Arbor Hospital
2012
Henry Ford Health System
2012
Duke Medical Center
2007
Abstract Background Intensive Care Unit (ICU) readmissions in patients with heart failure (HF) result a significant risk of death and financial burden for healthcare systems. Prediction at-risk readmission allows targeted interventions that reduce morbidity mortality. Methods results We presented process mining/deep learning approach the prediction unplanned 30-day ICU HF. A patient’s health records can be understood as sequence observations called event logs; used to discover model. Time...
Background— Peripheral arterial disease is a manifestation of systemic atherosclerosis and predictive future cardiovascular events. Clinical trial data have demonstrated that medical therapy can attenuate morbidity mortality in patients with peripheral disease. The utilization impact recommended contemporary population who undergo percutaneous interventions for lifestyle-limiting unknown. Methods Results— Using the Blue Cross Shield Michigan Cardiovascular Consortium Vascular Intervention...
Recent trials demonstrated the efficacy of prasugrel and ticagrelor compared with clopidogrel in reduction cardiovascular complications patients acute coronary syndrome (ACS). However, it is unclear how use 3 antiplatelet medications has changed commercially insured since advent new agents.To (a) describe adoption who received percutaneous intervention (PCI) for onset ACS (b) explore patient factors associated selection drug to provide insight into utilization patterns these agents.Patients...
In randomized controlled trials, prasugrel and ticagrelor reduced cardiovascular complications in patients with acute coronary syndrome (ACS) compared clopidogrel. However, limited head-to-head comparisons have been conducted across the three antiplatelet agents using real-world data. The aim of this study was to compare clinical outcomes strategies during a 1-year period after percutaneous intervention (PCI).Rates all-cause myocardial infarction (AMI) hospitalizations were retrospectively...
Purpose: Stable angina is ischemic chest pain on exertion or with emotional stress. Despite guideline-directed therapy, up to 30% of patients have suboptimal relief. The aims this study were to: (1) determine the feasibility and acceptability a randomized controlled trial (RCT) acupuncture; (2) evaluate preliminary efficacy acupuncture respect reduction increased functional status health-related quality life (HRQoL). Methods: Participants stable for ⩾1 month received either standardized...
Sabita Acharya, Barbara Di Eugenio, Andrew Boyd, Richard Cameron, Karen Dunn Lopez, Pamela Martyn-Nemeth, Carolyn Dickens, Amer Ardati. Proceedings of the 2018 Conference North American Chapter Association for Computational Linguistics: Student Research Workshop. 2018.
BACKGROUND: In patients with acute coronary syndrome (ACS) treated percutaneous intervention (PCI), newer antiplatelet agents prasugrel and ticagrelor have lower rates of cardiovascular events when compared clopidogrel. However, it is unclear whether there are differences in economic outcomes comparing these ACS-PCI patients. OBJECTIVE: To assess aggregated costs medical resource utilization among prescribed prasugrel, ticagrelor, or generic clopidogrel, using a large commercial insurance...
Most of the currently available health resources contain vast amount information that are created by keeping "general" population in mind, which reality, might not be useful for anyone. One approach to providing comprehensible patients is generate summaries personalized each individual. This paper details design a hospital-stay summary generation system tailors its content patient's understanding medical terminologies and their level engagement improving own health. Our were found cover...
Introduction: The role of Angiotensin-converting enzyme (ACE and ACE2) phenotypes polymorphisms in modulating severe acute respiratory syndrome coronavirus (SARS-- CoV2) infection hypertensive patients remains unclear. Our objective was to determine the distribution ACE ACE2 receptor by patient demographics correlate levels activity with SARS-CoV-2 outcomes. Methods: Hypertensive treated for at an urban emergency department (ED) were prospectively enrolled a cohort study between August 2020...
Background: Previous differences in guideline recommendation strength for CYP2C19 intermediate metabolizers may have limited genotype (PGx)-optimal post-percutaneous coronary intervention antiplatelet prescribing. Results: In this single-center retrospective observational cohort study of metabolizers, patients prescribed PGx-optimal therapy were younger and less likely on anticoagulation (2 vs 12%; p = 0.006). More possessed commercial insurance (36 7%; < 0.001), which was a predictor...